Schmiedl U P, Nelson J A, Teng L, Starr F, Malek R, Ho R J
Department of Radiology, University of Washington School of Medicine, Seattle, USA.
Acad Radiol. 1995 Nov;2(11):994-1001. doi: 10.1016/s1076-6332(05)80702-0.
We studied the intestinal absorption of manganese mesoporphyrin (Mn-mesoporphyrin), a potential oral hepatobiliary contrast agent.
Mn-mesoporphyrin was complexed with monoolein and taurocholate (mixed micelles). Portal venous delivery and biliary excretion were measured after intestinal administration in rats and rabbits, and the mechanism of intestinal transport was studied in a combined lymph-bile fistula model in rats. T1-weighted magnetic resonance (MR) images of the liver were obtained in rats and domestic pigs before and after gastric administration of Mn-mesoporphyrin in mixed micelles.
A 2.2-fold increase of portal venous Mn concentration was found 90 min after intestinal administration of the complex. None was found in the lymph collected from the thoracic duct, indicating a transcellular transport mechanism through the intestinal mucosa with portal venous delivery. Mn-mesoporphyrin levels in bile peaked between 240 and 270 min after administration (200-fold increase). The greatest liver enhancement (20-90%) was measured 360 min after administration.
The feasibility of intestinal delivery of Mn-mesoporphyrin, a lipophilic hepatobiliary contrast agent was demonstrated.
我们研究了锰中卟啉(Mn-中卟啉)的肠道吸收情况,它是一种潜在的口服肝胆造影剂。
将Mn-中卟啉与单油酸甘油酯和牛磺胆酸盐(混合微团)复合。在大鼠和兔子肠道给药后,测量门静脉输送和胆汁排泄情况,并在大鼠的联合淋巴-胆汁瘘模型中研究肠道转运机制。在大鼠和家猪胃内给予Mn-中卟啉混合微团前后,获取肝脏的T1加权磁共振(MR)图像。
肠道给予复合物90分钟后,门静脉锰浓度增加了2.2倍。从胸导管收集的淋巴液中未发现锰,表明通过肠黏膜的跨细胞转运机制及门静脉输送。给药后240至270分钟之间,胆汁中的Mn-中卟啉水平达到峰值(增加200倍)。给药360分钟后,测量到最大肝脏强化(20 - 90%)。
证明了亲脂性肝胆造影剂Mn-中卟啉经肠道给药的可行性。